Zeo ScientifiX (ZEOX) Revenue Growth (5y) (2017 - 2026)
Zeo ScientifiX (ZEOX) Revenue Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 16.65% |
| Jan 31, 2026 | 1.11% |
| Oct 31, 2025 | 10.96% |
| Jul 31, 2025 | 11.22% |
| Apr 30, 2025 | 13.57% |
| Jan 31, 2025 | 9.36% |
| Oct 31, 2024 | 16.26% |
| Jul 31, 2024 | 13.52% |
| Apr 30, 2024 | 25.59% |
| Jan 31, 2024 | 45.67% |
| Oct 31, 2023 | 41.79% |
| Jul 31, 2023 | 42.72% |
| Apr 30, 2023 | 55.63% |
| Jan 31, 2023 | 20.70% |
| Oct 31, 2022 | 40.61% |
| Jul 31, 2022 | 59.37% |
| Apr 30, 2022 | 65.44% |
| Jan 31, 2022 | 386.80% |
| Oct 31, 2021 | 120.62% |
| Jul 31, 2021 | 123.17% |